Focus Areas

Treatments for lung disease

We are leveraging the novel mechanism of action of ensifentrine to develop innovative treatments for lung disease.

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition without a cure. It damages the airways and lungs, leading to debilitating breathlessness.

Non-Cystic Fibrosis Bronchiectasis (NCFB) is a chronic lung disease with no FDA-approved treatment. Patients suffer from persistent cough, excess sputum production and frequent respiratory infections.

Cystic fibrosis (CF) is a potentially fatal genetic disease characterized by the build-up of thick, sticky mucus and infection that can damage many of the body’s organs.

Asthma is a common chronic inflammatory disease that makes it harder to move air in and out of the lungs.

Developing novel therapeutics for respiratory diseases

We welcome inquires from healthcare professionals seeking to learn more.